Home › Therapeutic areas › Metabolic › Classical Homocystinuria
Classical Homocystinuria (2 companies)
Companies with an active program in Classical Homocystinuria.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Mkt cap | Programs |
|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals | GI/HepatologyInfectious Disease+3 Rare | 1 | Approved | $1.63B | 17 |
| TVTX | Travere Therapeutics | MetabolicRenal Rare | 1 | Approved | $4.76B | 7 |
No companies match.